Global Epigenetics Market Size (2024 - 2029)

Epigenetics Market Analysis

The epigenetics market is projected to register a CAGR of 16.1% during the forecast period (2022-2027).

Covid has significantly impacted the epigenetics market growth due to the importance of epigenetics in COVID-19 research. For instance, according to the study published in Clinical Epigenetics, titled 'The epigenetic implication in coronavirus infection and therapy' in October 2020, epigenetic alterations might play an essential role in the onset of coronavirus disease complications. Although numerous treatment options are being investigated, further research is urgently needed to discover a viable vaccine or safer chemotherapeutic medications, including epigenetic therapies, to combat this viral pandemic and create pre-and post-exposure COVID-19 prophylaxis. This will lead to increased adoption of epigenetics in discovering therapies for COVID-19 infection, thereby expected to drive the market growth over the forecast period.

Factors such as the rising prevalence of cancers, rise in funding in research and development in healthcare, and rising applications of non-oncological applications of epigenetics, among others, are expected to drive the market growth over the forecast period.

As per Globocan 2020, there were 19,292,789 new cancer cases were reported worldwide. This worldwide and extensive cancer threat remains a major driver for developing new cancer therapies that help in risk assessment, early diagnosis, and effective treatment monitoring.

In addition, rising healthcare research and development expenditure across the globe is further expected to drive the growth of this market over the forecast period. For instance, according to the World Health Organization in December 2021, the gross domestic research and development expenditure on health (health GERD) as a percentage of gross domestic product (GDP) in high-income countries is 0.21%. For upper middle and low-income countries, it is 0.02%. Such huge investments in healthcare research and development will drive market growth due to adopting epigenetics in research.

On the other hand, the high cost of epigenetics and the dearth of skilled professionals in epigenetic research is expected to hamper the market studied.

Epigenetics Industry Segmentation

As per the scope of this report, epigenetics, in simple terms, refers to the study of genetic effects that are not entirely encoded by the DNA sequence of an organism. Epigenetics mainly deals with gene expression. Epigenetics also refers to changes in the genome in terms of functionality, which do not involve changes in the nucleotide sequence. DNA methylation or histone modification is a mechanism that causes epigenetic changes. The Epigenetics Market is segmented by Product (Instruments, Kits, and Reagents, Others), Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases), Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.